pminews.it

Kolinpharma approves Business Plan 2019-2021

MILAN (AIMnews.it) - The industrial objectives to 2021 are: revenues 2021 in the range of Euro 14-16 million, doubled compared to 2018, and Ebitda margin 2021 in the range of 24-26%, up from about 20% in 2018.

 
 
 
 

15/04/2019

pminews.it

ILPRA COMPLETA LA STRATEGIA DI PRESIDIO DIRETTO NEI MERCATI CHIAVE DELL’EUROPA OCCIDENTALE

20/11/2025

pminews.it

ICF è CRIBIS Prime Company

19/11/2025

pminews.it

Tecno: Allegra Fortunato premiata dall’Institute of Directors come Sustainability Director of the Year 2025

19/11/2025

pminews.it

ICF: 9M25 EBITDA a 7,2 mln ed EBITDA margin al 13,3%

19/11/2025